Tesu Health is a promising startup founded in 2022 with the slogan "Evidence-based digital therapeutics platform for personalised management of chronic diseases." The company is dedicated to providing effective treatment solutions for individuals facing chronic diseases, boasting a proficient team of experts in software engineering, clinical medicine, pharmaceuticals, and private health insurance. Now headquartered in the esteemed Cambridge Science Park, Tesu Health is poised for global expansion. The company's focus on research and development, along with robust sales and marketing initiatives, aims to propel them into the international arena, with the ultimate vision of becoming a leading global digital therapeutics company. Anchored by a well-defined business plan encompassing market analysis, financial projections, and a strong management team, Tesu Health is confident in its ability to deliver positive outcomes for investors, customers, and stakeholders. Their innovative fusion of cutting-edge technology and clinical expertise positions Tesu Health as a transformative force in reshaping the treatment paradigm for individuals with chronic diseases. The company has recently secured a $50.00K Seed Round investment on 23 November 2023, demonstrating the confidence that investors have in their potential. With a foundation in biotechnology, digital health, health care, and health and wellness, Tesu Health presents an attractive opportunity for those interested in the digital therapeutics space, making them a startup to watch in the coming years.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $50.00K | - | 23 Nov 2023 |
No recent news or press coverage available for Tesu Health.